Emmanuelle J Meuillet Selected Research

4- dodecyl- N- (1,3,4- thiadiazol- 2- yl)benzenesulfonamide

1/2016	Improved Treatment of Pancreatic Cancer With Drug Delivery Nanoparticles Loaded With a Novel AKT/PDK1 Inhibitor.
3/2010	Molecular pharmacology and antitumor activity of PHT-427, a novel Akt/phosphatidylinositide-dependent protein kinase 1 pleckstrin homology domain inhibitor.
6/2009	In vitro and in vivo activity of novel small-molecule inhibitors targeting the pleckstrin homology domain of protein kinase B/AKT.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emmanuelle J Meuillet Research Topics

Disease

22	Neoplasms (Cancer) 03/2021 - 01/2004
5	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 06/2009
5	Adenocarcinoma 01/2021 - 05/2012
4	Inflammation (Inflammations) 04/2015 - 06/2010
4	Breast Neoplasms (Breast Cancer) 01/2015 - 01/2004
3	Carcinogenesis 04/2015 - 04/2003
2	Colonic Neoplasms (Colon Cancer) 01/2019 - 01/2004
2	Colorectal Neoplasms (Colorectal Cancer) 12/2012 - 06/2010
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2012 - 03/2010
2	Hypoxia (Hypoxemia) 11/2012 - 12/2009
1	Pancreatitis 11/2020
1	Chronic Disease (Chronic Diseases) 07/2017
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2017
1	Hyperlipidemias (Hyperlipidemia) 07/2017
1	Leukemia 07/2017
1	Melanoma (Melanoma, Malignant) 07/2017
1	Aneuploidy (Aneuploid) 02/2016
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2014
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2012
1	Lung Neoplasms (Lung Cancer) 10/2012
1	Weight Loss (Weight Reduction) 03/2010
1	Prostatic Neoplasms (Prostate Cancer) 01/2009
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2004
1	Hemolysis 01/2004

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2015 - 09/2004
4	Prostaglandins EIBA 01/2013 - 06/2010
3	Pharmaceutical PreparationsIBA 01/2016 - 01/2014
3	4- dodecyl- N- (1,3,4- thiadiazol- 2- yl)benzenesulfonamideIBA 01/2016 - 06/2009
3	ProstaglandinsIBA 03/2013 - 06/2010
3	Biological ProductsIBA 01/2013 - 06/2010
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 03/2011 - 06/2009
3	ThioredoxinsIBA 01/2009 - 09/2004
2	Imatinib Mesylate (Gleevec)FDA Link 07/2017 - 02/2016
2	Polylactic Acid-Polyglycolic Acid CopolymerIBA 01/2016 - 01/2014
2	Dinoprostone (PGE2)FDA Link 04/2015 - 03/2013
2	EnzymesIBA 04/2015 - 10/2012
2	platelet protein P47 (pleckstrin)IBA 01/2015 - 03/2010
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2012 - 09/2004
2	LipidsIBA 06/2010 - 09/2004
2	Protein Kinases (Protein Kinase)IBA 03/2010 - 04/2003
2	Phosphotransferases (Kinase)IBA 01/2009 - 09/2004
2	Phosphatidylinositols (Phosphatidylinositol)IBA 09/2008 - 09/2004
1	Arginine (L-Arginine)FDA Link 11/2020
1	Contrast MediaIBA 11/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	BiguanidesIBA 07/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2017
1	Atorvastatin (Lipitor)FDA Link 07/2017
1	Phenformin (Fenformin)IBA 07/2017
1	Sugar PhosphatesIBA 02/2016
1	Drinking WaterIBA 02/2016
1	DNA (Deoxyribonucleic Acid)IBA 02/2016
1	DeuteriumIBA 02/2016
1	CarbohydratesIBA 02/2016
1	Bevacizumab (Avastin)FDA Link 02/2016
1	Dextran SulfateIBA 04/2015
1	Carrier Proteins (Binding Protein)IBA 01/2015
1	cholesteryl succinateIBA 01/2014
1	sodium phosphate (trisodium phosphate)FDA LinkGeneric 01/2014
1	Acetyl Coenzyme A (Acetyl-CoA)IBA 01/2014
1	BuffersIBA 01/2014
1	CholesterolIBA 01/2014
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2014
1	Glucose (Dextrose)FDA LinkGeneric 01/2014
1	Metformin (Glucophage)FDA LinkGeneric 01/2014
1	Therapeutic UsesIBA 01/2014
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 03/2013
1	IntegrinsIBA 12/2012
1	TensinsIBA 11/2012
1	Biomarkers (Surrogate Marker)IBA 11/2012
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 11/2012
1	CytokinesIBA 10/2012
1	Phospholipases A2 (Phospholipase A2)IBA 06/2010
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 06/2010
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 03/2010
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2010
1	epidithiodiketopiperazineIBA 12/2009
1	Transcription Factors (Transcription Factor)IBA 12/2009
1	Oxidoreductases (Dehydrogenase)IBA 01/2009
1	SeleniumIBA 01/2009
1	Sodium SeleniteIBA 01/2009
1	Casein Kinase II (Casein Kinase 2)IBA 01/2009
1	ApigeninIBA 01/2009
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2009
1	Phospholipids (Phosphatides)FDA LinkGeneric 09/2008
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 09/2008
1	3-Phosphoinositide-Dependent Protein KinasesIBA 09/2008
1	Insulin Receptor Substrate ProteinsIBA 09/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2004
1	Semaxinib (SU5416)IBA 06/2004
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 06/2004
1	1- ((1- O- octadecyl- 2- O- methylglycero)phospho)- 3- deoxy- myo- inositolIBA 01/2004
1	WortmanninIBA 01/2004
1	2-Hydroxypropyl-beta-cyclodextrinIBA 01/2004
1	Dihydrotachysterol (AT 10)IBA 01/2004

Therapy/Procedure

3	Chemoprevention 03/2021 - 06/2010
3	Therapeutics 01/2021 - 01/2015
1	Microbubbles 01/2021
1	Ketogenic Diet 02/2016
1	Intravenous Administration 01/2004